FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323351010> ?p ?o ?g. }

• W4323351010 endingPage "91" @default.
• W4323351010 startingPage "90" @default.
• W4323351010 abstract "Abstract Background Adequate pain control in inflammatory bowel disease (IBD) can require opioids due to their high analgesic potency. The long-term use of opioids, however, is limited by the development of tolerance. This leads to reduced analgesic efficacy over time, resulting in escalating opioid dosing and thus increased risk of serious side effects. We previously demonstrated the safety and effectiveness of a novel pH-sensitive µ-opioid receptor (MOR) agonist, NFEPP, in a murine colitis pain model, but its tolerance potential with chronic administration is unknown. Purpose To assess the tolerance potential of NFEPP compared to its parent compound fentanyl during acute colitis in a preclinical mouse model. Method Acute colitis in C57BL/6 mice was induced using 2.5% dextran sulphate sodium for 5 days. NFEPP or fentanyl were then administered s.c. every 4 hours between 7am and 11pm over 5 days in daily increasing concentrations (0.4-1.5 mg/kg/d). Analgesic tolerance to opioids was assessed in conscious mice by measuring visceromotor responses (VMRs) to noxious colorectal distensions. Tolerance to the MOR agonist DAMGO in NFEPP or fentanyl treated mice was evaluated using patch-clamp recordings from dorsal root ganglion (DRG) neurons and extracellular recordings from lumbar splanchnic nerves that innervate the colon. Inflammation was assessed by macroscopic analyses, histological scoring and tissue-pH measurements of the inflamed colon. Group differences were analyzed using two-way ANOVA with Bonferroni′s or Tukey′s post-test (p-value &lt;0.05). Result(s) NFEPP significantly reduced VMRs before and after chronic NFEPP treatment (39% reduction, p&lt;0.05 vs. 41% reduction, p&lt;0.05, compared to baseline at 80 µl). No differences of NFEPP induced antinociceptive actions were observed comparing VMR measurements before and after chronic administration (p=0.44). However, the analgesic activity of fentanyl decreased over time with less VMR inhibition observed after chronic treatment compared to fentanyl naïve mice (p&lt;0.05). Cross tolerance testing between these two opioids revealed a loss of NFEPP- induced VMR inhibition in fentanyl treated mice, but fentanyl effects in the NFEPP treatment group remained unchanged. In patch-clamp recordings, DAMGO (100nM) evoked antinociceptive actions in DRG neurons from NFEPP treated mice (rheobase increase: 50%, p&lt;0.05, compared to vehicle) whereas no change in rheobase with DAMGO was observed in DRG neurons from fentanyl treated mice. Afferent nerve activity from lumbar splanchnic nerves in response to von Frey filament probing decreased after DAMGO (100nM) application in NFEPP treated mice (p&lt;0.05, compared to control probing), but showed no change in fentanyl treated mice. Colonic length, diameter, histological damage and tissue-pH did not differ between the two opioid treatment groups. Conclusion(s) Chronic administration of NFEPP during acute murine colitis does not lead to analgesic tolerance within the visceral nociceptive system, in contrast to its parent compound fentanyl. Please acknowledge all funding agencies by checking the applicable boxes below CCC Disclosure of Interest None Declared" @default.
• W4323351010 created "2023-03-08" @default.
• W4323351010 creator A5000631424 @default.
• W4323351010 creator A5002405971 @default.
• W4323351010 creator A5009214704 @default.
• W4323351010 creator A5012378805 @default.
• W4323351010 creator A5014761816 @default.
• W4323351010 creator A5018299866 @default.
• W4323351010 creator A5051455638 @default.
• W4323351010 creator A5053690102 @default.
• W4323351010 creator A5056180419 @default.
• W4323351010 creator A5090440920 @default.
• W4323351010 date "2023-03-01" @default.
• W4323351010 modified "2023-10-04" @default.
• W4323351010 title "A277 A NOVEL PH-SENSITIVE Μ-OPIOID RECEPTOR AGONIST THAT DOES NOT INDUCE TOLERANCE IN A COLITIS MOUSE MODEL" @default.
• W4323351010 doi "https://doi.org/10.1093/jcag/gwac036.277" @default.
• W4323351010 hasPublicationYear "2023" @default.
• W4323351010 type Work @default.
• W4323351010 citedByCount "0" @default.
• W4323351010 crossrefType "journal-article" @default.
• W4323351010 hasAuthorship W4323351010A5000631424 @default.
• W4323351010 hasAuthorship W4323351010A5002405971 @default.
• W4323351010 hasAuthorship W4323351010A5009214704 @default.
• W4323351010 hasAuthorship W4323351010A5012378805 @default.
• W4323351010 hasAuthorship W4323351010A5014761816 @default.
• W4323351010 hasAuthorship W4323351010A5018299866 @default.
• W4323351010 hasAuthorship W4323351010A5051455638 @default.
• W4323351010 hasAuthorship W4323351010A5053690102 @default.
• W4323351010 hasAuthorship W4323351010A5056180419 @default.
• W4323351010 hasAuthorship W4323351010A5090440920 @default.
• W4323351010 hasBestOaLocation W43233510101 @default.
• W4323351010 hasConcept C118552586 @default.
• W4323351010 hasConcept C126322002 @default.
• W4323351010 hasConcept C15490471 @default.
• W4323351010 hasConcept C168481208 @default.
• W4323351010 hasConcept C170493617 @default.
• W4323351010 hasConcept C2775862500 @default.
• W4323351010 hasConcept C2776281502 @default.
• W4323351010 hasConcept C2776401185 @default.
• W4323351010 hasConcept C2778938600 @default.
• W4323351010 hasConcept C2779794527 @default.
• W4323351010 hasConcept C2779886867 @default.
• W4323351010 hasConcept C2779985140 @default.
• W4323351010 hasConcept C2780775167 @default.
• W4323351010 hasConcept C2780820201 @default.
• W4323351010 hasConcept C2781063702 @default.
• W4323351010 hasConcept C2781072394 @default.
• W4323351010 hasConcept C42219234 @default.
• W4323351010 hasConcept C71924100 @default.
• W4323351010 hasConcept C98274493 @default.
• W4323351010 hasConceptScore W4323351010C118552586 @default.
• W4323351010 hasConceptScore W4323351010C126322002 @default.
• W4323351010 hasConceptScore W4323351010C15490471 @default.
• W4323351010 hasConceptScore W4323351010C168481208 @default.
• W4323351010 hasConceptScore W4323351010C170493617 @default.
• W4323351010 hasConceptScore W4323351010C2775862500 @default.
• W4323351010 hasConceptScore W4323351010C2776281502 @default.
• W4323351010 hasConceptScore W4323351010C2776401185 @default.
• W4323351010 hasConceptScore W4323351010C2778938600 @default.
• W4323351010 hasConceptScore W4323351010C2779794527 @default.
• W4323351010 hasConceptScore W4323351010C2779886867 @default.
• W4323351010 hasConceptScore W4323351010C2779985140 @default.
• W4323351010 hasConceptScore W4323351010C2780775167 @default.
• W4323351010 hasConceptScore W4323351010C2780820201 @default.
• W4323351010 hasConceptScore W4323351010C2781063702 @default.
• W4323351010 hasConceptScore W4323351010C2781072394 @default.
• W4323351010 hasConceptScore W4323351010C42219234 @default.
• W4323351010 hasConceptScore W4323351010C71924100 @default.
• W4323351010 hasConceptScore W4323351010C98274493 @default.
• W4323351010 hasIssue "Supplement_1" @default.
• W4323351010 hasLocation W43233510101 @default.
• W4323351010 hasOpenAccess W4323351010 @default.
• W4323351010 hasPrimaryLocation W43233510101 @default.
• W4323351010 hasRelatedWork W1966153991 @default.
• W4323351010 hasRelatedWork W2021995152 @default.
• W4323351010 hasRelatedWork W2045120136 @default.
• W4323351010 hasRelatedWork W2070795956 @default.
• W4323351010 hasRelatedWork W2156699887 @default.
• W4323351010 hasRelatedWork W2198150168 @default.
• W4323351010 hasRelatedWork W2921373958 @default.
• W4323351010 hasRelatedWork W4223970543 @default.
• W4323351010 hasRelatedWork W4308986892 @default.
• W4323351010 hasRelatedWork W4323351010 @default.
• W4323351010 hasVolume "6" @default.
• W4323351010 isParatext "false" @default.
• W4323351010 isRetracted "false" @default.
• W4323351010 workType "article" @default.